Micronics Gets $2.6M Grant for MDx Blood Screening | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Micronics today said that it has received a $2.6 million from the US Department of Defense to support development of its PanNAT system for point-of-care molecular diagnostics of infectious pathogens.

Redmond, Wash.-based Micronics is developing the sample-to-answer system for rapid disease detection. It said that the PanNAT system will directly detect multiple blood-borne pathogens, including hepatitis B and C and HIV, in fresh blood samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.